The Switching of manufacturing source for Busulfex injection® 6mg/ml

Kyowa Kirin wish to inform healthcare professionals that the company will be switching the current source of Busulfex Injection® from Ben Venue Laboratories (BVL) to a different manufacturer, DSM Pharmaceutical Inc (DSM). This action was taken in response to the shortcomings in the Good Manufacturing Practice (GMP) of BVL that was recently identified. As a precautionary measure, Kyowa Kirin will voluntarily undertake an exchange of the Busulfex injection® manufactured at BVL with a supply from a new source.

 
 
Healthcare professional, Therapeutic Products
Published:

Dear Healthcare Professional Letters

12 Dec 2019

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of the letters can be found on the MOH Alert System, which is accessible via the Health Professionals Portal (HPP), a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://www.hpp.moh.gov.sg and follow the procedures below to access the MOH Alert system.

Step 1: Select your profession under 'For Healthcare Professionals’.

Step 2: Click on 'Restricted Content' and log in via SingPass.

Step 3: Click on the MOH Alert icon under ‘Applications’.

Step 4: Click on the Drug Alert tab to view the DHCPLs.